BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 7811566)

  • 21. Efficacy of intra-arterial and intravenous prourokinase in an embolic stroke model evaluated by diffusion-perfusion magnetic resonance imaging.
    Takano K; Carano RA; Tatlisumak T; Meiler M; Sotak CH; Kleinert HD; Fisher M
    Neurology; 1998 Apr; 50(4):870-5. PubMed ID: 9566365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke.
    Niessen F; Hilger T; Hoehn M; Hossmann KA
    Stroke; 2003 Aug; 34(8):2019-24. PubMed ID: 12843350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of infarct volume and mortality by thrombolysis in a rat embolic stroke model.
    Overgaard K; Sereghy T; Boysen G; Pedersen H; Diemer NH
    Stroke; 1992 Aug; 23(8):1167-73; discussion 1174. PubMed ID: 1636193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The only evidence based neuroprotective therapy for acute ischemic stroke: thrombolysis.
    Köhrmann M; Schellinger PD; Schwab S
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):563-71. PubMed ID: 21619867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombolytic therapy.
    Brott T
    Neurol Clin; 1992 Feb; 10(1):219-32. PubMed ID: 1557004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue at risk of infarction rescued by early reperfusion: a positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke.
    Heiss WD; Grond M; Thiel A; von Stockhausen HM; Rudolf J; Ghaemi M; Löttgen J; Stenzel C; Pawlik G
    J Cereb Blood Flow Metab; 1998 Dec; 18(12):1298-307. PubMed ID: 9850142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thrombolysis of cerebral thromboembolism by urokinase in an animal model].
    Hirschberg M; Korves M; Koc I; Hofferberth B; Wiesmann W
    Schweiz Med Wochenschr; 1987 Nov; 117(46):1811-3. PubMed ID: 3423767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rat model of reproducible cerebral infarction using thrombotic blood clot emboli.
    Overgaard K; Sereghy T; Boysen G; Pedersen H; Høyer S; Diemer NH
    J Cereb Blood Flow Metab; 1992 May; 12(3):484-90. PubMed ID: 1569141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancing the efficacy of thrombolysis by AMPA receptor blockade with NBQX in a rat embolic stroke model.
    Meden P; Overgaard K; Sereghy T; Boysen G
    J Neurol Sci; 1993 Nov; 119(2):209-16. PubMed ID: 8277337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of intra-arterial tissue plasminogen activator and urokinase on autologous arterial emboli in the cerebral circulation of rabbits [corrected].
    Benes V; Zabramski JM; Boston M; Puca A; Spetzler RF
    Stroke; 1990 Nov; 21(11):1594-9. PubMed ID: 2122553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of body temperature on infarct volume and thrombolytic therapy in a rat embolic stroke model.
    Meden P; Overgaard K; Pedersen H; Boysen G
    Brain Res; 1994 May; 647(1):131-8. PubMed ID: 8069695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue plasminogen activator. Reduction of neurologic damage after experimental embolic stroke.
    Zivin JA; Lyden PD; DeGirolami U; Kochhar A; Mazzarella V; Hemenway CC; Johnston P
    Arch Neurol; 1988 Apr; 45(4):387-91. PubMed ID: 3128254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticoagulant-induced intracerebral bleeding in brain ischemia. Evaluation in 200 patients with TIAs, emboli from the heart, and progressing stroke.
    Bogousslavsky J; Regli F
    Acta Neurol Scand; 1985 Jun; 71(6):464-71. PubMed ID: 4024857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombolytic therapy in cerebrovascular disorders.
    Levine SR; Brott TG
    Prog Cardiovasc Dis; 1992; 34(4):235-62. PubMed ID: 1728786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Failure to improve the effect of thrombolysis by memantine in a rat embolic stroke model.
    Back T; Otto D; Kittner D; Schüler OG; Hennerici MG; Mennel HD
    Neurol Res; 2007 Apr; 29(3):264-9. PubMed ID: 17509225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotection by excitatory amino acid antagonist augments the benefit of thrombolysis in embolic stroke in rats.
    Sereghy T; Overgaard K; Boysen G
    Stroke; 1993 Nov; 24(11):1702-8. PubMed ID: 8236347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acute hyperglycemia and reperfusion therapy in stroke patients].
    Krajícková D
    Vnitr Lek; 2010 Apr; 56(4):295-300. PubMed ID: 20465099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombolytic therapy for stroke.
    Brott T
    Cerebrovasc Brain Metab Rev; 1991; 3(2):91-113. PubMed ID: 1854597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reperfusion therapy in acute cerebrovascular syndrome.
    Mazighi M; Amarenco P
    Curr Opin Neurol; 2011 Feb; 24(1):59-62. PubMed ID: 21102331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clot thickens--thrombolysis and combination therapies.
    Chopp M; Zhang RL; Zhang ZG; Jiang Q
    Acta Neurochir Suppl; 1999; 73():67-71. PubMed ID: 10494344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.